UNSPSC 51282421: Piperacillin anhydrous

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C23H27N5O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9I628532GX, chemically known as piperacillin, anhydrous, but more generally known as piperacillin anhydrous, which bears US NIH Compound Identifier 43672. European Medicines Agency schedules piperacillin anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09867MIG.

Most nations, for tariff purposes, schedule piperacillin anhydrous under HS 29411090. Piperacillin anhydrous bears US NLM identifiers UMLS ID C1882383 and NCI Concept Code C61891. SMILES: CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2CCCCC2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O.

UNSPSC 51282421 Piperacillin anhydrous, a Commodity code, shows minimal direct recent activity in state and local procurement. The code nominally covers a specific antibiotic pharmaceutical, but the recent opportunities posted under this classification do not reflect piperacillin procurement; instead, they address naloxone, drug deactivation systems, pharmacy benefit program strategy, medical and first aid supplies for fire departments, and generic multi-source pharmaceuticals through cooperative purchasing. The mismatch between the code's narrow pharmaceutical scope and the actual solicitations posted suggests either tagging errors in the source system or that piperacillin demand is too low or specialized to generate standalone state and local RFPs, RFQs, or ITBs at present.

The four posted opportunities span state health agencies (Texas HHS Commission), county health departments (Seminole County, Florida), cities (Tampa), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). Geographic reach includes Florida, Texas, Minnesota, and Oregon, with the cooperative purchasing vehicle (MMCAP) showing the broadest multistate footprint. Representative recent activity includes Seminole County's IFB for naloxone and drug deactivation systems with a July 26, 2023 deadline; the City of Tampa's ITB for medical and first aid supplies (estimated contract $700,000) with an March 13, 2026 deadline and a 5% small local business enterprise bid discount; the Texas HHS Commission's RFI on direct-to-manufacturer prescriptions posted April 3, 2026; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products due March 26, 2026, serving state and local facilities across multiple jurisdictions through three authorized wholesalers. Piperacillin itself does not appear in any named solicitation, suggesting the code carries minimal current procurement volume or relevance at the state and local level.